NK Cell Treatment in India

Stem cells aid in the formation of new cells in healthy tissues and can aid in the recovery of tissues that have been wounded or destroyed. They act as the base for the different cell types that make up many of the body's organs. Stem cells differ from most cells in many ways: they can self-renew, divide over an extended period of time, and under certain conditions, be induced to differentiate into specialised cells with distinct functions.

Adult stem cells remain in the body throughout life and contribute to the maintenance and restoration of organs, but have limited developmental ability. Embryonic stem cells, on the other hand, can divide indefinitely and give rise to any cell type in the body, making them the most flexible source of cells for study and transplantation therapy.

There are a variety of stem cell origins used in science. The inner cell mass of a blastocyst is used to obtain embryonic stem cells, formed as a fertilised egg divides into a hollow ball of around 150 cells. Throughout the body, stem cells can also be present in differentiated tissues and organs.

NK cells are a type of white blood cell that forms part of the body's innate immune system, with the ability to recognize and act against abnormal cells.

They are related but distinct. Both involve isolating and expanding cells in a lab, but NK cells are mature immune cells rather than stem cells. See our production of stem cells page for comparison.

A blood sample is collected, NK cells are isolated from it, expanded in a controlled lab environment, and tested for quality before being prepared for administration.

Yes. It is treated as investigational under India's National Ethical Guidelines for Biomedical and Health Research (ICMR, 2017), the same framework covering stem cell applications.

This is assessed individually during a free medical evaluation, based on the specific condition and case.

No. It remains investigational, and individual outcomes are not guaranteed. See our safety and guarantees page.

They are complementary, not interchangeable. NK cell treatment supports function and recovery directly, while Exosome Therapy for Retinal Detachment targets vision loss from a detached retina at the cellular level; some patients use both as part of one care plan.

Yes. NK cell treatment and Exosome Therapy for Retinopathy address different aspects of recovery, and the two are often coordinated within the same care plan for patients dealing with retinal blood-vessel damage, often diabetes-related, when both are clinically appropriate.

Some do. Patients researching nerve pain and numbness from diabetes sometimes explore Exosome Therapy for Diabetic Neuropathy as a complementary option alongside NK cell treatment, with the combination assessed case-by-case during a free medical evaluation.

It can be. Exosome Therapy for Muscular Dystrophy is a separate regenerative option some patients consider alongside NK cell treatment when managing progressive muscle weakness, coordinated by the clinical team rather than self-directed.

They are complementary, not interchangeable. NK cell treatment supports function and recovery directly, while Exosome Therapy for Osteoporosis targets low bone density and fracture risk at the cellular level; some patients use both as part of one care plan.

Yes. NK cell treatment and Exosome Therapy for Parkinson’s Disease address different aspects of recovery, and the two are often coordinated within the same care plan for patients dealing with tremor, rigidity, and movement symptoms, when both are clinically appropriate.

Some do. Patients researching autoimmune joint inflammation sometimes explore Exosome Therapy for Rheumatoid Arthritis as a complementary option alongside NK cell treatment, with the combination assessed case-by-case during a free medical evaluation.

It can be. Exosome Therapy for Sciatic Nerve Injury & Sciatica is a separate regenerative option some patients consider alongside NK cell treatment when managing sciatic nerve pain radiating down the leg, coordinated by the clinical team rather than self-directed.

They are complementary, not interchangeable. NK cell treatment supports function and recovery directly, while Exosome Therapy for Shoulder Injury targets rotator cuff and shoulder joint damage at the cellular level; some patients use both as part of one care plan.

Yes. NK cell treatment and Exosome Therapy for Spinal Cord Injury address different aspects of recovery, and the two are often coordinated within the same care plan for patients dealing with loss of motor or sensory function after cord damage, when both are clinically appropriate.

Some do. Patients researching motor-neuron loss and progressive weakness in SMA sometimes explore Exosome Therapy for Spinal Muscular Atrophy as a complementary option alongside NK cell treatment, with the combination assessed case-by-case during a free medical evaluation.

It can be. Exosome Therapy for Sports Injuries is a separate regenerative option some patients consider alongside NK cell treatment when managing soft-tissue and joint injuries from athletic activity, coordinated by the clinical team rather than self-directed.

They are complementary, not interchangeable. NK cell treatment supports function and recovery directly, while Exosome Therapy for Systemic Lupus targets autoimmune inflammation affecting multiple organs at the cellular level; some patients use both as part of one care plan.

Yes. NK cell treatment and Exosome Therapy for Wound Healing address different aspects of recovery, and the two are often coordinated within the same care plan for patients dealing with slow-healing or chronic wounds, when both are clinically appropriate.